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Abstract
Colorectal cancer is the third most commonly diagnosed cancer in the United States.
Historically, the Appalachian region of Kentucky has experienced disparities in colorectal cancer
screening and survival as compared to both the non-Appalachian region of the state and the
United States. The aim of this paper is to investigate the differences in cancer staging and
survival after diagnosis in Appalachian and non-Appalachian Kentuckians. The present time
period of study is a retrospective, population-based cohort with data taken from the Kentucky
Cancer Registry. Binomial logistic regression and Cox proportional hazards models were used to
estimate unadjusted and adjusted odds ratios and hazard ratios, respectively. Of colorectal cancer
cases, 61% of Appalachian (n=1875) and 58.8% of non-Appalachian (n=3843) cases were late
stage. There were 749 colorectal cancer related deaths among Appalachians and 1527 deaths
among non-Appalachians. A multivariable binomial logistic regression model found the odds of
late-stage cancer diagnosis were 1.08 (95% CI: 0.99-1.18) times higher for Appalachians. A
multivariable Cox proportional hazards model found the hazards of cancer related mortality were
1.03 (95% CI: 0.94-1.13) times higher for Appalachians. Both adjusted models produced
insignificant associations between Appalachian residence and the outcomes of interest. Further
investigation is needed to fully understand the factors that influence cancer disparity in
Appalachia.
1. Introduction
1.1. Background
Despite declines in both incidence and mortality in past decades, colorectal cancer is the
third most commonly diagnosed cancer in both men and women in the United States (Siegel et
al., 2017). Higher rates of diagnoses are in part due to nationwide efforts to increase colorectal
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cancer screenings, although improvements have varied by state. Kentucky has had the highest
increase in colorectal cancer screening rates among all states, with a 53% increase between 1999
and 2016 (Kentucky Cancer Consortium Colon Cancer Committee, 2018). As colorectal cancer
screening rates have increased in Kentucky, colorectal cancer incidence and mortality have
decreased by 23% and 30%, respectively (Kentucky Cancer Consortium Colon Cancer
Committee, 2018). Increased screening, as well as improvements to treatment and historical
improvements to colorectal cancer risk factors, are associated with decreases in colorectal cancer
incidence and mortality (Siegel et al., 2017).
Disparities in colorectal cancer staging and survival have been identified in those with
lower socioeconomic status both domestically (Clegg et al., 2002) and abroad (Kweon et al.,
2017) (Booth et al., 2010). This association has been seen in other cancer sites as well, including
but not limited to lung, prostate, breast, and cervical cancers (Booth et al., 2010) (Lantz et al.,
2006). Colorectal cancer disparity in Kentucky begins at the point of screening, as those with
less than a high school education and those with a household income of less than $25,000 are at a
greater risk of not having been screened when compared to their more educated and higher
income counterparts (Kentucky Department for Public Health & The Centers for Disease Control
and Prevention, 2018).
The Appalachian region of the United States faces many health disparities (Arnold,
2017); notably, cancer is among the highest contributors to excess morbidity and mortality in the
area (Appalachian Regional Commission, 2017). In Appalachia, the leading cause of death is
cancer, as opposed to the rest of the United States where it is heart disease (Arnold, 2017). The
cancer disparity in Appalachia has been present historically, as it has been shown that between
1969 and 2011, cancer incidence rates were 36% higher in rural Appalachian Kentucky counties
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than in non-Appalachia urban areas nationwide (Cavallo, 2017) (Arnold, 2017). This difference
in incidence was underscored by an increase of 182.2 to 195.2 cases per 100,000 during the same
specified time frame (Cavallo, 2017). Appalachians experience a disparity in colorectal cancer
survival as well; as after age-adjustment, Appalachians have a mortality rate of 20.6 compared to
a non-Appalachian rate of 16.9 per 100,000 (Kentucky Cancer Consortium, 2019). Furthermore,
the 3- and 5-year rates for cancer survival are lower for Appalachians when compared to nonAppalachians; 57% and 50% of cancer patients survive at least 3 and 5 years, respectively, in
Appalachia, while 65% and 58% of cancer patients survive at least 3 and 5 years urban, nonAppalachian areas (Cavallo, 2017).
Colorectal cancer screening efforts in Kentucky have increased over recent years, but not
as rapidly as in the non-Appalachian area of the state (Kentucky Department for Public Health,
2017). The present literature suggests that potential reasons for lower cancer screening rates in
Appalachian Kentucky include a lack of access to healthcare, limited financial resources, and
lower education levels (Schoenberg et al., 2012a). There is a continued need to identify potential
associations between the population at risk and colorectal cancer staging and survival
(Schoenberg et al., 2012a).
1.2. Setting
Appalachia is a distinct geographic region of the eastern United States, comprised of 420
counties across 13 states (Appalachian Regional Commission, 2018). Of Kentucky’s 54
Appalachian-designated counties, 38 counties have been identified by the Appalachian Regional
Commission as financially distressed and 13 others are considered at-risk (Appalachian Regional
Commission, 2018). Kentucky has the highest rate of poverty among Appalachian states, where
nearly a quarter of Appalachians (25.4%) are considered impoverished, compared to 18.9% of
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those in non-Appalachian counties (Fahe, 2019). Unemployment, however, is not a primary
contributor to this disparity, but rather that those employed make significantly less than the
average American ($30,308 vs. $46, 049, respectively) (Fahe, 2019). These earnings are
potentially associated with the level of educational attainment in the region, as 77% of adults
over 25 in Appalachian Kentucky counties have graduated high school, compared to the state
average of 90% and the national average of 85% (National Center for Education Statistics,
2018).
Current qualitative research suggests that individuals in the Appalachian region of Kentucky
also tend to hold attitudes toward healthcare that may serve as a barrier to colorectal cancer
screenings and treatment (Schoenberg et al., 2012a). Appalachians report lack of awareness of
and access to screening and cancer resources, embarrassment and concern about screening
practices, and a lack of trust towards the medical establishment (Schoenberg et al., 2012a).
Appalachians also report a lack of knowledge of family histories, as cancer is viewed as a
stigmatized condition and therefore there is a reluctance to share information on diagnoses
(Schoenberg et al., 2012a). These attitudes are cited as factors that contribute to the stagnation in
screening rates in the area.
1.3. Cancer Staging and Survival
Colorectal cancer staging begins at 0 (in situ), the earliest, and then ranges from stage I (1) to
stage IV (4) (American Cancer Society, 2020). The American Joint Committee on Cancer
defines the colorectal cancer stages as follows: stage I is cancer that has grown through the
muscularis mucosa into the submucosa, potentially grown into the muscularis propria, and has
not spread to nearby lymph nodes or distant sites; stage II is cancer that has grown into, though,
or past the outermost layers of the colon or rectum, potentially attached to a nearby organ, and
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has not spread to nearby lymph nodes or distant sites; stage III cancer is cancer that has grown
into, though, or past the outermost layers of the colon or rectum, potentially attached to a nearby
organ, has spread to nearby lymph nodes or the tissue surrounding them, and has not spread to
distant sites; stage IV cancer is that has may or may not have grown through the colon or rectum,
may or may not have spread to nearby lymph nodes, and has spread to a distant organ or to
distant parts of the peritoneum. For the purpose of this study, SEER summary staging guidelines
will be followed. Early-stage will correspond with stage I cancers (localized) and late-stage will
correspond with stage II-IV cancers (regional and distant).
Late-stage cancer diagnosis is a strong predictor for fewer years of survival after
diagnosis, both in the United States and internationally (Clegg et al., 2002) (Ortiz-Ortiz et al.,
2016). When diagnosed at an early stage, treatment for colorectal cancer is significantly more
effective and often less aggressive than when diagnosed at a late state, increasing the patient’s
likelihood of survival (Andrew et al., 2018). Because of this, there is a present need to further
identify characteristics of patients that may put them at a higher risk of a late-stage colorectal
cancer diagnosis.
A variety of factors are associated with stage at diagnosis, including those regarding the
patient’s biological or genetic risk factors, their sociodemographic characteristics, or specific
information related to their medical treatment and access to care. Evidence suggests that cancer
specific characteristics, such as tumor grade and lymph node involvement, are associated with
increased cancer stage progression, increasing the likelihood that the cancer will be diagnosed at
a later stage (Bal et al., 2012). Race is a significant demographic characteristic associated with
cancer stage at diagnosis in the United States, but there is strong evidence that a portion of this
association is due to factors such as lower income and educational attainment that have been
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historically associated with minority populations in the U.S. (Lantz et al., 2006). Higher
household income and education level has been shown to be associated with earlier stages of
cancer diagnosis and lower rates of cancer related mortality (Tomic et al., 2018). Socioeconomic
status may also explain disparities between timeliness of care, as it has been observed that
patients who experience delays between symptom onset and diagnosis or enter the healthcare
system through the emergency room rather than through a primary care provider have a higher
risk of late-stage diagnosis (Ortiz-Ortiz et al., 2016). Access to care is a multifaceted issued.
Spatial access to care has been associated with cancer survival as well, as patients who are
farther from treatment centers are at an increased risk of cancer related mortality (Cramb et al.,
2012). Financial access to care in the United States is often determined by insurance type, and it
has been seen that patients without an insurance provider are at a significantly greater risk of
late-stage cancer diagnosis and poorer cancer related outcomes (Fayanju et al., 2013).
Socioeconomic status influences many of the potential risk factors associated with latestage diagnosis of colorectal cancer. Further research is needed to better identify individuals who
may be at risk through their relationship between SES and additional risk factors; improved
understanding of these relationships will better help clinicians target screening interventions and
inform decisions in medical care.
1.4. Study Objective
Current literature suggests that there is a clear relationship between lower socioeconomic
status (SES) and worse cancer outcomes, particularly years of survival after diagnosis (Booth et
al., 2010). Later stage diagnoses in those with lower SES may potentially be a contributor to
higher cancer mortality among this population (Byers et al., 2008). Differences in survival
between those of lower SES and those of higher SES have been observed across genders, age
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groups, and races and ethnicities (Thomson et al., 2001) (Lantz et al., 2006). The Appalachian
region of Kentucky is characterized by lower than average household income, lower levels of
educational attainment, less accessible healthcare systems, and cultural attitudes associated with
lower colorectal cancer screening uptake (Schoenberg et al., 2012a). Because of the multitude of
risk factors facing this population, the purpose of this paper is to investigate the differences in
cancer staging and survival after diagnosis in Appalachian and non-Appalachian Kentuckians.
1.5. Research Hypothesis
The current study aims to investigate the relationship between Appalachian residence in
Kentucky with respect to colorectal cancer staging and survival. The study will investigate two
hypotheses:
Hypothesis 1: The stage at which colorectal cancer is diagnosed will be later for residents who
live in an Appalachian designated Kentucky county when compared to non-Appalachian
residents.
Hypothesis 2: Years lived after colorectal cancer diagnosis will be fewer for residents who live
in an Appalachian designated Kentucky county when compared to non-Appalachian residents.
2. Methods
2.1. Data Source
2.1.1. Kentucky Cancer Registry
The present study is a retrospective, population-based cohort with data taken from the
Kentucky Cancer Registry (KCR). Mandatory case reporting to the KCR began January 1, 1991
after legislation was passed by the State General Assembly to establish the KCR as the state’s
population based central cancer registry (Kentucky Cancer Registry, 2020). KCR actively
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monitors for cancer cases, collects follow-up information after diagnosis, and links to state and
national vital record keeping agencies (Kentucky Cancer Registry, 2020). The KCR has been a
part of the National Cancer Institute’s (NCI) Surveillance Epidemiology and End Results
(SEER) program for over two decades (est. 2000), has participated in the Center for Disease
Control and Prevention’s (CDC) National Program of Cancer Registries (NPCR), and has
consistently received the highest rating for completeness, accuracy, and timeliness from the
North American Association of Central Cancer Registries.
2.1.2. Study Cohort
The cohort selected for the present study included all primary colorectal cancer cases aged 18
years or older diagnosed in Kentucky between January 1st, 2012 and December 31st, 2017.
Inclusion criteria limited the study cohort to cases that were invasive (stage I-IV), alive at time of
diagnosis, and were first and only primary cases. Exclusion criteria excluded those with in situ or
stage 0 cancer, those who were diagnosed through an autopsy or death record, or those who had
previous or subsequent cancer diagnoses. The initial sample supplied by KCR comprised of
10,044 complete cases. Participants were excluded due to unknown race (n=71) and unknown
cancer stage (n=363) The final sample included 9,610 participants. 1851 participants were
excluded from survival-specific analyses due to unrelated cause of death, resulting in a sample
size of 7,829.
2.2. Variables Included in Analysis
The variables listed below were used in the following analyses. Descriptions of variables
and variable manipulation is provided.
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•

Sex – The variable used for sex is categorical; patients were identified as either male
or female. Transgender individuals were assigned to the sex they were assigned at
birth to account for potential biological associations.

•

Race – The variable used for race is categorical; patients were grouped as
White/Other and Black.

•

Age – The variable used for age group is continuous; this variable represents the
patient’s age at time of diagnosis.

•

Age group - The variable used for age group is categorical; patients were grouped as
less than 50 years aged, between 50 and 69 years aged, or above 70 years aged.

•

Year of Diagnosis – The variable used for year of diagnosis is categorical; diagnosis
years range between 2012 and 2017.

•

Appalachian Status - The variable used for race is categorical; patients were
identified as either from an Appalachian or non-Appalachian Kentucky county at the
time of diagnosis.

•

Primary payer – The variable used for primary payer is categorical; patients were
grouped by either having had a type of private insurance, Medicaid, Medicare, no
insurance, and unknown insurance type.

•

Stage at diagnosis – The variable used for stage at diagnosis is categorical; patients
were grouped as early-stage (localized) or late-stage (regional or distant). Stage is
determined by the 2000 SEER Summary Staging Guide.

•

Marital status - The variable used for marital status is categorical; patients were
grouped at time of diagnosis as married/partnered or single (including those who
were separated, divorced, or widowed).
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•

Survival interval – The variable used for survival interval is continuous; this variable
represents the months from diagnosis to either last contact or death.

•

Survival status – The variable used for survival status is categorical; patients were
grouped as either alive, dead due to the primary colorectal cancer tumor, or dead due
to reasons unknown or unrelated to the primary colorectal cancer tumor.

2.3. Statistical Analysis
Sociodemographic, diagnostic, and survival factors were examined to investigate the
associations between Appalachian status and colorectal cancer stage at diagnosis and survival.
Exploratory data analysis and descriptive statistics of categorical variables consisted of counts
and percentages generated for both the overall sample and the sample stratified by the primary
exposure of interest, Appalachian status. The significance of categorical variable associations
between the stratified results was assessed by preforming Pearson's chi-squared test (χ2).
Significance testing for continuous variables was assessed by preforming independent samples ttest. All p-values calculated were two-sided with a 0.05 significance level.
Univariate and multivariable binomial logistic regression models were used to identify
differences in association between exposure groups through the use of odds ratios and 95%
confidence intervals. The variables found to be independently associated with the outcome of a
late-stage colorectal cancer diagnosis were racial group, primary insurance payer, and partner
status. Clinical and academic evidence also supports the inclusion of age in the model (Kweon et
al., 2017) (Cramb et al., 2012). The final logistic regression model estimated the odds of latestage colorectal cancer diagnosis for Appalachian Kentuckians, adjusting for racial group,
primary insurance payer, partner status, and age in years.
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Univariate and multivariate Cox proportional-hazards models were used to identify
differences in survival after colorectal cancer diagnosis between exposure groups through the use
of hazards ratios and 95% confidence intervals. The variables found to be independently
associated with the outcome of survival were stage at diagnosis, sex, age, primary payer, and
marital status. Backward selection with a significance level of 0.05 supported this decision. The
final Cox proportional hazards model estimated the hazard of colorectal cancer survival for
Appalachian Kentuckians, adjusting for diagnosis, sex, age, primary payer, and marital status.
Estimated correlation matrices were generated for logistic regression and proportionalhazards models to identify potential multicollinearity between variables. No collinearity within
either model was found.
Kaplan-Meier curves were generated for Appalachian status and stage of diagnosis to
visualize survival trends from time of diagnosis to last follow-up or confirmed death.
All analyses were performed using SAS statistical software (SAS Institute, Inc., Cary, NC,
USA).
3. Results
As seen in Table 1, between 2012 and 2017, a total of 9,610 primary cases of invasive
colorectal cancer were diagnosed in alive individuals in the state of Kentucky. Of those
diagnosed, 59.50% were considered late-stage at time of diagnosis. The sample was primarily
non-Appalachian (68.01%), non-Black (93.26%), married (55.10%) and above 50 years of age
(86.25%), with the average age being 63.94 years old. There were fairly even proportions of
males and females (52.59% vs. 47.41% respectively). Colorectal cancer diagnoses were
consistent over the 5-year study time frame. The majority of individuals primary payer at time of
treatment, or insurance type, was Medicare (51.07%), followed by private insurance (29.20%),
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Medicaid (10.65%), an unknown insurance type (6.08%) and uninsured (2.61%). Using data
from the most recent contact or notification of death, it was found that much of the sample was
alive (57.05%), with 23.69% of the sample having died from the cancer or complications caused
by the cancer identified at time of diagnosis.
Table 1. Basic characteristics of total sample (n = 9,610)
Total
Stage at diagnosis
Early
Late
Appalachian Status
Non-Appalachian
Appalachian
Sex
Male
Female
Race
White/Other
Black
Age in years
(mean, SD)
Age Group
<50
50-69
>70
Year of Diagnosis
2012
2013
2014
2015
2016
2017
Primary Payer
Private
Uninsured
Medicaid
Medicare
Unknown
Marital Status
Married/Partnered

n
(%)
9610 100.00
3892
5718

40.50
59.50

6536
3074

68.01
31.99

5091
4590

52.59
47.41

8962
648

93.26
6.74

63.94

13.85

1321
4891
3395

13.75
50.89
35.36

1577
1578
1625
1608
1605
1617

16.41
16.42
16.91
16.73
16.70
16.83

2819
251
1030
4939
584

29.20
2.61
10.65
51.07
6.08

5295

55.10

15

Single
Unknown
Vital Status
Alive
Dead (cancer related)
Dead (cancer unrelated)

4077
238

42.42
2.48

5482
2276
1851

57.05
23.69
19.26

When the total sample was stratified by Appalachian (n=6536) and non-Appalachian
(n=3074) residence in Table 2, significant differences were found among select
sociodemographic characteristics. Appalachian individuals were more often diagnosed at a later
stage of colorectal cancer (p-value=0.041), with 61.00% of diagnoses in Appalachians being
late-stage as compared to 58.80% of non-Appalachian diagnoses. Individuals diagnosed with
colorectal cancer from Appalachia were less racially diverse than their non-Appalachian
counterparts (p-value=<0.0001), with 1.30% cases being Black versus 9.03% of cases,
respectively. There was a statistically significant, although clinically insignificant, difference in
the average age at diagnosis (p-value=<0.0001), with the average age of Appalachians being
63.62, compared to 64.22 years of age in non-Appalachians. While clinical or practical
significance is unlikely, there were statistically significant differences in calendar year of
diagnoses between residence groups (p-value=0.024). Non-Appalachian cases had a fairly even
distribution of diagnoses per year between 2012 and 2017, while Appalachian cases peaked in
2014 (571 cases) and have been slightly declining thereafter (502 cases in 2017). Primary payer
at time of diagnosis differed between groups as well (p-value=<0.0001), with a higher proportion
of Appalachian cases utilizing Medicare (54.81%) and Medicaid (13.21%) than nonAppalachians (49.79% and 9.55% respectively). The increased utilization of public insurance is
countered by a decreased utilization of private insurance, with 21.80% of Appalachians utilizing
a private insurance provider, 10% less than their non-Appalachian counterparts (32.68%).

16

Appalachians were also married significantly more often (p-value = 0.017) than nonAppalachians (56.25% and 54.59%, respectively).
Variables found to have statistically insignificant differences between exposure group
were sex (p-value=0.083), age group (p-value=0.082), and vital status (p-value=0.287).
Table 2. Basic characteristics stratified by Appalachian Status (n=9,681)
Non-Appalachian
(n=6536)

Stage at diagnosis
Early
Late
Sex
Male
Female
Race
White/Other
Black
Age in years
(mean, SD)
Age Group
<50
50-69
>70
Year of Diagnosis
2012
2013
2014
2015
2016
2017
Primary Payer
Private
Uninsured
Medicaid
Medicare
Unknown
Marital Status
Married/
Partnered

Appalachian
(n=3074)

n

(%)

n

(%)

p-value

2693
3843

41.20
58.80

1199
1875

39.00
61.00

0.041

3393
3143

51.91
48.09

1654
1420

53.81
46.19

0.083

5928
608

90.70
9.03

3034
40

98.70
1.30

<0.0001

64.22

13.95

63.62

13.55

<0.0001

888
3288
2360

13.59
50.31
36.11

433
1603
1038

14.09
52.15
33.77

0.082

1106
1093
1053
1084
1084
1115

16.92
16.72
16.13
16.59
16.59
17.06

471
485
571
524
521
502

15.32
15.78
18.58
17.05
16.95
16.33

0.024

2136
171
624
3254
351

32.68
2.62
9.55
49.79
5.37

670
80
406
1685
233

21.80
2.60
13.21
54.81
7.58

<0.0001

3566

54.59

1729

56.25

0.017
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Single
Unknown
Vital Status
Alive
Dead
(cancer
related)
Dead
(cancer
unrelated)
p-value for chi-square test

2823
147

43.19
2.25

1254
91

40.79
2.96

3762
1527

55.97
24.37

1720
749

55.97
24.37

1247

19.66

604

19.66

0.287

Table 3 summarizes univariate logistic regression estimates for sociodemographic
characteristics of the sample. Univariate logistic regression estimated that the odds of having a
late-stage colorectal cancer diagnosis were 1.01 (95% CI: 1.00-1.20) times higher for those of
Appalachian residence compared to those of non-Appalachian residence. This model estimates a
statistically insignificant association between Appalachian residence and late-stage colorectal
cancer diagnosis. Significant associations between late-stage cancer diagnosis and other
variables of interest were found.
Primary payer method was found to be both significantly and insignificantly associated
with the outcome of interest. Cases that were uninsured (OR: 1.73, 95% CI: 1.31-2.29) or used
Medicaid (OR: 1.22, 95% CI: 1.06-1.42) had a higher odds of late-stage colorectal cancer
diagnosis than those with private insurance (reference group); however, cases whose primary
payer was unknown (OR: 0.81, 95% CI: 0.68-0.97) had significantly decreased odds of late-stage
colorectal cancer diagnosis when compared to those who had private insurance. Medicare
utilization was insignificantly associated with stage of diagnosis (OR: 1.01, 95% CI: 0.998-1.20).
It was found that the odds of having a late-stage colorectal cancer diagnosis were 1.15
(95% CI: 1.05-1.25) times higher for those who were single than those who were married at time

18

of diagnosis. Those of unknown marital status had insignificantly decreased odds of late-stage
colorectal cancer diagnosis that those who were married at time of diagnosis (OR: 0.86, 95% CI:
0.67-1.12).
Variables found to have statistically insignificant associations with the outcome of
interest were sex (p-value=0.105), race (p-value=0.146), and age (p-value=0.929).
Table 3. Univariate logistic regression odds ratios (n = 9,681)
Late-stage diagnosis
OR (95% CI)
Appalachian Status
Non-Appalachian
1 (reference)
Appalachian
1.10 (1.00-1.20)
Sex
Male
1 (reference)
Female
0.94 (0.86-1.01)
Race
White/Other
1 (reference)
Black
0.89 (0.76-1.04)
Age
By year
1.000 (0.997-1.003)
Primary Payer
Private
1 (reference)
Uninsured
1.73 (1.31-2.29)
Medicaid
1.22 (1.06-1.42)
Medicare
1.10 (1.00-1.20)
Unknown
0.95 (0.79-1.14)
Marital Status
Married/Partnered
1 (reference)
Single
1.15 (1.05-1.25)
Unknown
0.86 (0.67-1.12)
OR: odds ratio, 95% CI: 95% confidence interval
p-value for Wald chi-square

p-value

0.041

0.105

0.146
0.929

<0.001
0.007
0.056
0.577

0.001
0.273

Table 4 summarizes multivariable logistic regression estimates for key sociodemographic
characteristics of the sample. multivariable logistic regression estimated that the odds of having a
late-stage colorectal cancer diagnosis were 1.08 (95% CI: 0.99-1.18) higher for those of
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Appalachian residence compared to those of non-Appalachian residence, after adjusting for sex,
marital status, marital status, racial group, and age in years. Therefore, this model estimates a
statistically insignificant association between Appalachian residence and late-stage colorectal
cancer diagnosis after adjustment. Significant associations between late-stage cancer diagnosis
and other variables of interest were also found within the adjusted model.
After adjustment, the two primary payer methods that were previously significant remain
so. Uninsured individuals (OR: 1.67, 95% CI: 1.26-2.22) and those who utilize Medicaid (OR:
1.17, 95% CI: 1.01-1.36) remain significantly associated with greater odds of late-stage
colorectal cancer diagnosis when compared to those with private insurance. The significance of
the relationship between those with Medicare (p-value=0.199) or those with unknown insurance
status (p-value=0.547) with the outcome of interest remains absent after adjustment.
It was estimated that the odds of late-stage colorectal cancer diagnosis were 0.92 (95%
CI: 0.84-0.99) times lower for cases that were female compared to cases that were male, after
adjustment for the previously mentioned variables.
Of those who were single and whose marital status was unknown, only the association
between single individuals and the outcome remained significant. After adjustment, the odds of
late-stage colorectal cancer diagnosis were 1.15 (95% CI: 1.05-1.25) times higher for those who
were single than those who were married. Unknown marital status was statistically insignificant
(p-value=0.24) after adjustment.
Additional variables found to have statistically insignificant associations with the
outcome of interest after inclusion in the adjusted logistic regression model were race (pvalue=0.100) and age in years (p-value=0.666).
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Table 4. Multivariate logistic regression odds ratios– adjusting for sex, marital status,
primary payer, racial group, and age (n = 9,681)
Late-stage diagnosis
OR (95% CI)
Appalachian Status
Non-Appalachian
1 (reference)
Appalachian
1.08 (0.99-1.18)
Sex
Male
1 (reference)
Female
0.92 (0.84-0.99)
Race
White/Other
1 (reference)
Black
0.87 (0.74-1.03)
Age
By year
0.999 (0.995-1.003)
Primary Payer
Private
1 (reference)
Uninsured
1.67 (1.26-2.22)
Medicaid
1.17 (1.01-1.36)
Medicare
1.08 (0.96-1.22)
Unknown
0.95 (0.79-1.13)
Marital Status
Married/Partnered
1 (reference)
Single
1.15 (1.05-1.25)
Unknown
0.85 (0.66-1.11)
OR: odds ratio, 95% CI: 95% confidence interval
p-value for Wald chi-square

p-value

0.104

0.0362

0.100
0.666

<0.001
0.037
0.199
0.547

0.002
0.243

Table 5 summarizes univariate Cox proportional hazards estimates for diagnostic and
sociodemographic characteristics of the sample. Univariate Cox proportional hazards estimated
that the hazards of colorectal cancer related mortality were 1.06 (95% CI: 0.97-1.16) times
higher for those of Appalachian residence compared to those of non-Appalachian residence. This
model estimates a statistically insignificant association between Appalachian residence and
colorectal cancer related mortality. However, significant associations between colorectal cancer
related mortality and other variables of interest were found.
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Stage at diagnosis was estimated to have an increased hazard of colorectal cancer related
mortality among variables investigated. It was estimated that the hazard of colorectal cancer
related mortality was 9.9 (95% CI: 8.53-11.49) times higher for those with a late-stage colorectal
cancer diagnosis compared to those diagnosed at an early stage.
Age in years was also significantly associated with the outcome, as it was estimated that
with each year of age, the hazard of colorectal cancer related mortality was 1.029 (95% CI:
1.025-1.032) times higher than the last.
As was seen with the previous univariate model in Table 3, each primary payer was
significantly associated with the outcome, however in this model all types of payer method were
associated with an increased hazard. Cases that were uninsured (HR: 2.26, 95% CI: 1.80-2.84),
used Medicaid (HR: 1.49, 95% CI: 1.28-1.73), used Medicare (HR: 1.93, 95% CI: 1.75-2.15), or
whose insurance status was unknown (HR: 1.40, 95% CI: 1.16-1.69) had a higher hazard of
colorectal cancer related mortality than those with private insurance.
Marital status showed significant associations regarding single and unknown individuals.
It was estimated that that the hazard of colorectal cancer related mortality were 1.56 (95%
CI:1.43-1.69) times higher for those who were single at time of diagnosis than those who were
married and 1.51 (95% CI:1.17-1.94) times higher for those of unknown marital status.
Additional variables found to be insignificantly associated with colorectal cancer related
mortality include sex (p-value=0.517) and race (p-value=0.828).
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Table 5. Univariate Cox proportional hazard ratios (n=7,759)
Cancer related mortality
Stage at diagnosis
Early
Late
Appalachian Status
Non-Appalachian
Appalachian
Sex
Male
Female
Race
White/Other
Black
Age
By year
Primary Payer
Private
Uninsured
Medicaid
Medicare
Unknown
Marital Status
Married/Partnered
Single
Unknown
HR: hazard ratio, 95% CI: 95% confidence interval
p-value for Wald chi-square

HR (95% CI)

p-value

1 (reference)
9.90 (8.53-11.49)

<0.0001

1 (reference)
1.06 (0.97-1.16)

0.183

1 (reference)
0.97 (0.90-1.06)

0.517

1 (reference)
1.02 (0.87-1.20)

0.828

1.029 (1.0251.032)

<0.0001

1 (reference)
2.27 (1.80-2.85)
1.49 (1.28-1.73)
1.93 (1.75-2.14)
1.40 (1.16-1.69)

<0.0001
<0.0001
<0.0001
0.001

1 (reference)
1.56 (1.43-1.69)
1.51 (1.17-1.94)

<0.0001
0.001

Further investigation into univariate associations between primary variables of interest,
specifically Appalachian residence and cancer stage at diagnosis, prompted the use of KaplanMeier curves to visualize survival from time of diagnosis to most recent follow up. Figure 1 and
figure 2 show survival estimates for Appalachian residence and stage at diagnosis, respectively.
Figure 1 finds a statistically insignificant (p-value=0.1808) relationship between Appalachian
residence and survival over time. However, there does appear to be the beginnings of a
divergence between the two populations near the 95th month of follow up, where a noticeable
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drop in survival probability is seen. Figure 2 finds a statistically significant (<0.0001) difference
between early- and late-stage individuals and survival over time. The difference between
populations is clear throughout the full follow up period and is most noticeable within the first
twenty months.
Figure 1. Kaplan-Meier Curve – survival estimate for Appalachian and non-Appalachian
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Figure 2. Kaplan-Meier Curve – survival estimate for early- and late-stage cancer
diagnoses

Table 6 summarizes multivariate Cox proportional hazards estimates for diagnostic and
sociodemographic characteristics of the sample. Multivariate Cox proportional hazards estimated
that the hazards of colorectal cancer related mortality were 1.03 (95% CI: 0.95-1.13) times
higher for those of Appalachian residence compared to those of non-Appalachian residence, after
adjusting for stage at diagnosis, sex, age, primary payer, and marital status. This model estimates
a statistically insignificant association between Appalachian residence and colorectal cancer
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related mortality. However, significant associations between colorectal cancer related mortality
and other variables of interest were found.
Stage at diagnosis was again estimated to have the highest increased hazard of colorectal
cancer related mortality among variables investigated. It was estimated that the hazard of
colorectal cancer related mortality was 9.92 (95% CI: 8.55-11.52) times higher for those with a
late-stage colorectal cancer diagnosis compared to those diagnosed at an early stage after
adjustment.
Sex became statistically significant when included in the adjusted model. It was
estimated that the hazards of colorectal cancer related mortality were 0.89 (95% CI: 0.82-0.97)
times lesser for those who were female than those who were male.
Age in years was also significantly associated with the outcome, nearly unchanged from
the univariate model, as it was estimated that with each year of age the hazard of colorectal
cancer related mortality was 1.03 (95% CI: 1.03-1.04) times higher than the last after adjustment.
After adjustment, primary payer remained significantly associated with the outcome,
however in this model three of the four types of payer method were associated with an increase
in hazards. Cases that were uninsured (HR: 1.83, 95% CI: 1.45-2.30), used Medicaid (HR: 1.34,
95% CI: 1.14-1.56), or whose insurance status was unknown (HR: 1.40, 95% CI: 1.15-1.69) had
a higher hazards of colorectal cancer related mortality than those with private insurance.
However, after adjustment the relationship between those with Medicare and colorectal cancer
related mortality became statistically insignificant (HR: 1.01, 95% CI: 0.97-1.24).
Marital status showed significant associations regarding both single individuals and
individuals of unknown marital status within this model. It was estimated that that the hazard of
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colorectal cancer related mortality was 1.40 (95% CI:1.29-1.53) times higher for those who were
single at time of diagnosis than those who were married. The association between unknown
marital status and colorectal cancer related mortality, after inclusion in the adjusted model, were
also found to be statistically significant (HR: 1.56, 95% CI: 1.21-2.01).
Appalachian residence and Medicare utilization were found to be the only insignificant
variables within the adjusted Cox proportional hazards model with respect to colorectal cancer
related mortality.

Table 6. Multivariable Cox proportional hazard ratios – adjusting for stage at diagnosis,
sex, age, primary payer, and marital status (n=7,829)
Cancer related mortality
HR (95% CI)
Stage at diagnosis
Early
1 (reference)
Late
9.92 (8.55-11.52)
Appalachian Status
Non-Appalachian
1 (reference)
Appalachian
1.03 (0.94-1.13)
Sex
Male
1 (reference)
Female
0.88 (0.82-0.97)
Age
By year
1.03 (1.03-1.04)
Primary Payer
Private
1 (reference)
Uninsured
1.83 (1.45-2.30)
Medicaid
1.34 (1.14-1.56)
Medicare
1.10 (0.97-1.24)
Unknown
1.40 (1.15-1.69)
Marital Status
Married/Partnered
1 (reference)
Single
1.40 (1.29-1.53)
Unknown
1.56 (1.21-2.01)
HR: hazard ratio, 95% CI: 95% confidence interval
p-value for Wald chi-square

p-value

<0.0001

0.484

0.006
<0.0001

<0.0001
<0.001
0.155
0.001

<0.0001
0.001
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4. Discussion
Late-stage cancer diagnosis is a strong predictor of poor survival probability, however,
sociodemographic characteristics at the individual level have been previously found to be
associated with late-stage diagnoses (Ortiz-Ortiz et al., 2016) (Tomic et al., 2018). The
Appalachian portion of Kentucky is a distinct region of the state, characterized by low
socioeconomic status, a lack of access to care, and historically high presence of health behaviors
associated with poor health outcomes (Schoenberg et al., 2012a) (Arnold, 2017). Because of this,
the objective of this study was to investigate the relationship between Appalachian residence and
colorectal cancer stage at diagnosis and survival. The present study additionally explored the
relationships between key sociodemographic characteristics available from individual medical
record/cancer registry data and the outcomes previously mentioned.
Descriptive summaries provided found significant differences between Appalachian and nonAppalachian residents with respect to stage at diagnosis, race, age, year diagnosed, and primary
payer. These findings are consistent with the current literature regarding sociodemographic
differences within this population (Fleming et al., 2011) (Schoenberg et al., 2012b). General
summaries stratified by Appalachian residence also showed many sociodemographic
characteristics to be heterogenous within the population. Of note, Appalachian residents in
Kentucky are in large majority white and primary utilize publicly provided forms of insurance.
While this may imply there are significantly less persons of color within the Appalachian
community, it does not negate the disparity highlighted by previous literature between white and
black individuals in Appalachia regarding cancer outcomes (Antwi et al., 2013). Differences
with respect to insurance group may be explained through a higher proportion of the
Appalachian population qualifying for Medicaid eligibility, with household income at under
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138% of the Federal Poverty Guidelines (Kentucky Cabinet for Health and Family Services,
2017).
An initial univariate model found significant associations between Appalachian residence
and late-stage colorectal cancer diagnosis; however, after adjusting for historically and
significantly associated confounding variables, the relationship became insignificant. These
findings suggest that despite proportional differences between Appalachian and non-Appalachian
individuals regarding stage at time of diagnosis, the relationship can be partially explained by
sociodemographic characteristics such as age, insurance status, and martial status. For decades, it
has been well supported that increases in age are associated with increases in colorectal cancer
incidence and mortality (Cooper et al., 1995). Differences in insurance provider have also shown
associations with stage at diagnosis, with specific emphasis on uninsured populations past
literature (Greenbaum et al., 2012). While the present study found that uninsured individuals had
the highest odds of late-stage colorectal cancer diagnosis within the adjusted model, the
proportion of uninsured individuals in Appalachian and non-Appalachian counties is comparable
(2.59% vs. 2.63%, respectively). This could imply some generalizability between populations
regarding late-stage diagnosis risk. Marital status has also been found to be associated with latestage colorectal cancer diagnosis within SEER registries, with married individuals presenting the
higher proportions of early-stage diagnoses (Li et al., 2015).
Univariate hazards models initially displayed an insignificant relationship (p-value=0.183)
between Appalachian residence and colorectal cancer related mortality. The statistical
significance of the relationship diminished further (p-value=0.484) after the multivariable model
adjusted for stage at diagnosis, sex, age, primary payer, and marital status. Each variable
included in the adjusted model, except Appalachian status, showed a significant relationship with
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cancer related survival. The Appalachian region of Kentucky has historically had significantly
higher rates of colorectal cancer related mortality than other regions of the state and country
(Blackley et al., 2012). The present study did not find significant associations between
Appalachian residence and colorectal cancer survival; therefore, this could imply that the
associations seen between Appalachian status and colorectal cancer mortality are significantly
explained by the characteristics presently explored, or by characteristics outside the scope of the
present study.
Findings from this study indicate a greater need to explore other factors associated with stage
at diagnosis in Appalachian individuals as it is clearly the most significant contributor to
increased cancer related mortality (HR: 9.92, CI: 8.55-11.52). Additional research should further
investigate individual and community level characteristics that may be associated with colorectal
cancer screening utilization among Appalachian and non-Appalachian individuals, as previous
research suggests a strong relationship between screening utilization, earlier stage of diagnosis,
and improved cancer related survival (Fleming et al., 2011).
4.1. Public health impact
By the end of 2021, the American Cancer Society projects 149,500 new colorectal cancer
cases and 52,980 deaths within the US (American Cancer Society, 2021). While the mortality
rate has dropped over past decades, colorectal cancer mortality in those younger than 55 has
increased by 1% each year between 2008 and 2017 (American Cancer Society, 2021). Because
of this and other trends previously explored regarding staging and survival, it is imperative that
research and resources are directed toward underserved areas of the country that could be most
impacted. The present study provides affirmation of preexisting literature and acts to generate
hypotheses for future research. Reproducibility is necessary within all contexts of research, and

30

the present study was able to find similar results to past research and confirm findings found in
other comparable populations. The present study’s findings differed at times from published
literature as well, and further investigation into these differences should be considered.
4.2. Strengths and Limitations
The greatest strength of this study is its use of population-based, individual case level data
for all analyses. Because of this, the present study can be confident all primary colorectal cancer
cases, alive at time of diagnosis, were identified within the study population. However, analyses
are limited to Appalachian counties in Kentucky and is therefore not applicable to other
Appalachian areas. Of the initial 10,044 cases, 363 were excluded due to missing cancer stage
information and 1,851 of the remaining cases were excluded from survival analyses due to
unrelated causes of death, potentially limiting the strength of claims made regarding the present
study’s results. An additional potential limitation could be the rational used to group individuals
within categorical variables, such as race being operationalized as White/other and Black. While
this has the potential to impact findings, the decision to do so is supported by previous literature
and is analytically necessary due to extremely small minority populations within Appalachia. An
additional positive of the present study is that it also investigated sociodemographic
characteristics outside of Appalachian residence and could control for them during analyses.
4.3. Conclusions
In conclusion, significant associations between late-stage colorectal cancer diagnosis and
Appalachian residence are seen within the study population, even when adjusting for multiple
sociodemographic characteristics historically and statistically associated with the exposure and
outcome of interest. A significant association between Appalachian residence and colorectal
cancer related survival could not be found within the study population and follow up time frame
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with or without adjusting for stage at diagnosis and related sociodemographic characteristics.
Further research is necessary to explore the associations, and lack thereof, between Appalachians
and colorectal cancer outcomes.
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